1. Home
  2. GPAT vs ORGO Comparison

GPAT vs ORGO Comparison

Compare GPAT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPAT
  • ORGO
  • Stock Information
  • Founded
  • GPAT 2020
  • ORGO 1985
  • Country
  • GPAT United States
  • ORGO United States
  • Employees
  • GPAT N/A
  • ORGO N/A
  • Industry
  • GPAT
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPAT
  • ORGO Health Care
  • Exchange
  • GPAT NYSE
  • ORGO Nasdaq
  • Market Cap
  • GPAT 365.5M
  • ORGO 418.7M
  • IPO Year
  • GPAT 2024
  • ORGO N/A
  • Fundamental
  • Price
  • GPAT $10.17
  • ORGO $3.34
  • Analyst Decision
  • GPAT
  • ORGO Strong Buy
  • Analyst Count
  • GPAT 0
  • ORGO 2
  • Target Price
  • GPAT N/A
  • ORGO $5.00
  • AVG Volume (30 Days)
  • GPAT 25.9K
  • ORGO 607.1K
  • Earning Date
  • GPAT 01-01-0001
  • ORGO 02-27-2025
  • Dividend Yield
  • GPAT N/A
  • ORGO N/A
  • EPS Growth
  • GPAT N/A
  • ORGO N/A
  • EPS
  • GPAT 0.30
  • ORGO N/A
  • Revenue
  • GPAT N/A
  • ORGO $455,038,000.00
  • Revenue This Year
  • GPAT N/A
  • ORGO $9.65
  • Revenue Next Year
  • GPAT N/A
  • ORGO $1.57
  • P/E Ratio
  • GPAT $33.63
  • ORGO N/A
  • Revenue Growth
  • GPAT N/A
  • ORGO 1.34
  • 52 Week Low
  • GPAT $9.98
  • ORGO $2.17
  • 52 Week High
  • GPAT $10.18
  • ORGO $4.57
  • Technical
  • Relative Strength Index (RSI)
  • GPAT N/A
  • ORGO 53.23
  • Support Level
  • GPAT N/A
  • ORGO $2.88
  • Resistance Level
  • GPAT N/A
  • ORGO $3.24
  • Average True Range (ATR)
  • GPAT 0.00
  • ORGO 0.16
  • MACD
  • GPAT 0.00
  • ORGO 0.04
  • Stochastic Oscillator
  • GPAT 0.00
  • ORGO 90.29

About GPAT GP-ACT III ACQUISITION CORP

GP-Act III Acquisition Corp is a blank check company.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Share on Social Networks: